| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
STARNET is a genetics of RNA expression study of multiple disease-relevant tissues obtained from living patients with cardiovascular disease. Tissue samples are obtained from blood, atherosclerotic-lesion-free internal mammary artery (MAM) and atherosclerotic aortic root (AOR), subcutaneous fat (SF), visceral abdominal fat (VAF), skeletal muscle (SKLM), and liver (LIV) during open thorax surgery of 600 coronary artery disease (CAD) patients. All patients gave written informed consent. The inclusion criterion was eligibility for coronary artery by-pass graft (CABG) surgery. Patients with other severe systemic diseases, such as active systemic inflammatory disease or cancer, were excluded. The primary clinical end points were the SYNTAX score based on the extent of coronary atherosclerosis assessed from preoperative angiograms. The STARNET patients are Caucasians (31% females); 32% had diabetes, 75% had hypertension, and 67% had hyperlipidemia; and 33% had an MI before age 60. By New York Heart Association criteria, 45% were class I, 42% class II, 9% class III, and 1% class IV.
TYPES AND RNA SEQUENCING: 566 DNA genotype and 3577 RNA-seq profiles from seven tissues from 600 STARNET CABG patients passed quality control (on average 511 RNA-seq profiles/tissue). DNA was genotyped with the OmniExpress Exome array (Illumina, ~900k SNPs) and imputed to a total of 14,098,063 DNA variant calls (6,245,505 with minor allele frequency >5%). The STARNET subjects mainly overlap with Caucasian of Northern European (Finnish) descent. RNA sequencing was performed using the HighSeq2000 platform, poly-A (LIV, SKLM, VAF, SF and blood) and ribo-zero (AOR, MAM) protocols with 50-100 bp read lengths, single end to 15-30 million read depth.
- Study Design:
- Case Set
- Study Type:
- Case Set
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data (Public ftp)
- Study Inclusion/Exclusion Criteria
Described in Franzén et al., Science, 2016
- Molecular Data
-
Type Source Platform Number of Oligos/SNPs SNP Batch Id Comment RNA Sequencing Illumina HiSeq 2000 N/A N/A - Study History
Described in Franzén et al., Science, 2016
- Selected publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Coronary Artery Disease
- Links to Related Resources
- Authorized Data Access Requests
- Study Attribution
-
-
Principal Investigator
- Johan Björkegren, M.D., Ph.D. Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology Icahn School of Medicine at Mount Sinai, New York, NY, USA.
-
Funding Sources
- 5R01HL125863-02. National Institutes of Health, Bethesda, MD, USA.
- Research Council. Karolinska Institutet, Solna, Sweden.
- Joint Research Program in Translational Science. AstraZeneca, Wilmington, DE, USA.
- Torsten och Ragnar Söderberg Foundation. Stockholm, Sweden.
- Leducq Foundation, Paris, France.
- CVgenes@target. München, Germany.
- Clinical Gene Networks AB. Stockholm, Sweden.
- Knut och Alice Wallenberg Foundation. Stockholm, Sweden.
- American Heart Association. Dallas, TX, USA.
- Department of Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, NY, USA. Icahn School of Medicine at Mount Sinai, NY, USA.
-
Principal Investigator